Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis

Published:2014-05-21 Issue:6 Volume:7 Page:1492-1503
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Shih D Q,Zheng L,Zhang X,Zhang H,Kanazawa Y,Ichikawa R,Wallace K L,Chen J,Pothoulakis C,Koon H W,Targan S R

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/mi201437.pdf

Reference36 articles.

1. Cosnes, J. et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm. Bowel Dis. 8, 244–250 (2002).

2. Peyrin-Biroulet, L. & Lemann, M. Review article: remission rates achievable by current therapies for inflammatory bowel disease. Aliment. Pharmacol. Ther. 33, 870–879 (2011).

3. Johnson, L.A., Luke, A., Sauder, K., Moons, D.S., Horowitz, J.C. & Higgins, P.D. Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a “Top-Down” approach to intestinal fibrosis in mice. Inflamm. Bowel Dis. 18, 460–471 (2012).

4. Hardie, W.D., Le Cras, T.D., Jiang, K., Tichelaar, J.W., Azhar, M. & Korfhagen, T.R. Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 286, L741–L749 (2004).

5. Lavaud, S. et al. Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats. Am. J. Physiol. Renal Physiol. 280, F683–F694 (2001).

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD;Gut;2024-09-11

2. Antibodies Targeting the Tumor Necrosis Factor-Like Ligand 1A in Inflammatory Bowel Disease: A New Kid on the (Biologics) Block?;Digestion;2024-07-26

3. Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma;Respiratory Research;2024-07-10

4. The current landscape of antifibrotic therapy across different organs: A systematic approach;Pharmacological Research;2024-07

5. Inflammation accelerating intestinal fibrosis: from mechanism to clinic;European Journal of Medical Research;2024-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3